|
|
|
Volumn 50, Issue 1, 2008, Pages 12-21
|
|
Asymmetric dimethylarginine--mechanisms and targets for therapeutic management.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
ARGININE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DRUG DERIVATIVE;
ENDOTHELIAL NITRIC OXIDE SYNTHASE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
N,N DIMETHYLARGININE;
N,N-DIMETHYLARGININE;
BLOOD;
DRUG ANTAGONISM;
ESTROGEN THERAPY;
HUMAN;
HYPERCHOLESTEROLEMIA;
METABOLISM;
PHYSIOLOGY;
REVIEW;
VASCULAR ENDOTHELIUM;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ARGININE;
ENDOTHELIUM, VASCULAR;
ESTROGEN REPLACEMENT THERAPY;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
HYPERCHOLESTEROLEMIA;
HYPOGLYCEMIC AGENTS;
NITRIC OXIDE SYNTHASE TYPE III;
|
|
EID: 45949092381
PISSN: 02048043
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (5)
|
|
References (39)
|
